Feed URL: https://blogs.kent.ac.uk/bio-profiles/2013/08/28/dr-emma-hargreaves/feed/?withoutcomments=1
Dr Emma Hargreaves joined the School of Biosciences in February 2007
Career
1999 –2003
University of Kent at Canterbury BSc (Hons.) Biochemistry. Including 2001 –2002 industrial trainee within the orphan G-Protein Coupled Receptor (oGPCR) group of Pfizer, Sandwich, U.K.
2003
Summer studentship within the Drug Metabolism group of Pfizer, Sandwich U.K. Research interest in cytochrome P450 inhibitors.
2003-2007
PhD in clinical pharmacology in the group of Dr. Anthony Davenport, University of Cambridge. The emerging pharmacology of orphan GPCRs.
2007-2009
Post-Doctoral Research Associate in the group of Prof. Mark Smales, University of Kent. Characterising post-transcriptional constraints that determine recombinant protein yield during bioprocessing in mammalian cells.
2010-2011
Senior Post-Doctoral Research Associate in the group of Prof. Mark Smales, University of Kent. Generation of cell lines with improved protein synthesis/mRNA translation and growth characteristics for enhanced mAb production.
2012-Present
Leverhulme Early Career Fellow, University of Kent. Determining control of mRNA translation via changes of translation factor levels.